A small molecule inhibitor of Notch1 modulates stemness and suppresses breast cancer cell growth.
Ontology highlight
ABSTRACT: Although breast cancer stem cells (BCSCs) are well characterized, molecularly targeting and eradicating this sub-population remains a challenge in the clinic. Recent studies have explored several signaling pathways that govern stem cell activation: We and others established that the Notch1 signaling plays a significant role in the proliferation, survival, and differentiation of BCSCs. Earlier, we reported that a newly developed small molecule, ASR490, binds to the negative regulatory region (NRR: The activation switch of the Notch receptor) of Notch1. In vitro results demonstrated that ASR490 significantly inhibited BCSCs (ALDH+ and CD44+/CD24-) and breast cancer (BC) growth at nM concentrations, and subsequently inhibited the colony- and mammosphere
SUBMITTER: Saran U
PROVIDER: S-EPMC9998682 | biostudies-literature | 2023
REPOSITORIES: biostudies-literature
ACCESS DATA